ACT Lung Health Intervention: Phase Two

Recruiting N/A Interventional Study
Smoking Cessation Smoking Behaviors Smoking, Tobacco Smoking, Cigarette Smoking (Tobacco) Addiction
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 100
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
50 (estimated)
Sponsor
Dana-Farber Cancer Institute · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study aims to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Self-identify as either Chinese or Korean * Speak either Korean, Mandarin, or English * Are 18 years of age or older * Are current smokers (i.e., have smoked at least 100 traditional cigarettes ever and have smoked at least one traditional cigarette within the prior 30 days) *…
Contacts

Mary Cooley, PhD

617-632-5096

mary_cooley@dfci.harvard.edu

CONTACT

Barbara Halpenny, MA, MSW

617-582-7124

barbara_halpenny@dfci.harvard.edu

CONTACT